The invention relates to a process for the preparation of ribociclib of formula V or its salts. The invention provides novel crystalline forms of ribociclib succinate and ribociclib trifluoroacetate. The present invention also relates to pharmaceutical compositions comprising a crystalline form of ribociclib succinate and at least a pharmaceutically acceptable carrier. It further relates to the use of such compositions in the treatment of cancer.

Sokhi, S.S., Singh, G., Lahiri, S., et al. (2019). An Improved Process for The Preparation of Ribociclib and its Salts.

An Improved Process for The Preparation of Ribociclib and its Salts

Cabri W
2019

Abstract

The invention relates to a process for the preparation of ribociclib of formula V or its salts. The invention provides novel crystalline forms of ribociclib succinate and ribociclib trifluoroacetate. The present invention also relates to pharmaceutical compositions comprising a crystalline form of ribociclib succinate and at least a pharmaceutically acceptable carrier. It further relates to the use of such compositions in the treatment of cancer.
2019
WO2019082143
Sokhi, S.S., Singh, G., Lahiri, S., et al. (2019). An Improved Process for The Preparation of Ribociclib and its Salts.
Sokhi; S.S.; Singh; G.; Lahiri; S.; Pandey; M.K.; Tiwari; R.N.; Shukla; S.; Musmade; S.M.; Dua; H.; Cabri W
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/767831
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact